← Back to Search

Clinical Evaluation and Comparison of the Tecnis Symfony Optiblue and Tecnis Symfony IOLs

N/A
Waitlist Available
Led By Daniel H Chang, MD
Research Sponsored by Empire Eye and Laser Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 week post-op visit first and second eye, 1 month post-op visit, 6 month post-op visit
Awards & highlights
No Placebo-Only Group

Summary

The goal of this clinical study is to compare the Tecnis Symfony Optiblue intraocular lens implant to the Tecnis Symfony intraocular lens implant in patients over 22 years old with cataracts in both eyes. The main questions it aims to answer are: Which lens has less nighttime side effects? Which lens has higher patient satisfaction? Participants will undergo a minimum of 7 study visits where they will complete a variety of vision tests and vision questionnaires.

Eligible Conditions
  • Presbyopia
  • Cataract
  • Pseudoaphakia

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 week post-op visit first and second eye, 1 month post-op visit, 6 month post-op visit
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 week post-op visit first and second eye, 1 month post-op visit, 6 month post-op visit for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Patient reported nighttime dysphotopsia symptoms
Secondary study objectives
Low contrast visual acuity with glare
Patient overall satisfaction
Other study objectives
Binocular UCDVA
Distance of subjective near blur
Lens findings/complications
+9 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Tecnis Symfony OptiblueExperimental Treatment1 Intervention
Tecnis Symfony Optiblue/Tecnis Symfony Optiblue Toric (ZXR00V/ZXW150)
Group II: Tecnis SymfonyActive Control1 Intervention
Tecnis Symfony/Tecnis Symfony Toric (ZXR00/ZXT150)
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Tecnis Symfony Optiblue/Tecnis Symfony Optiblue Toric (Models ZXR00V/ZXW150)
2022
N/A
~60

Find a Location

Who is running the clinical trial?

Johnson & Johnson Surgical Vision, Inc.Industry Sponsor
37 Previous Clinical Trials
8,595 Total Patients Enrolled
2 Trials studying Presbyopia
339 Patients Enrolled for Presbyopia
Empire Eye and Laser CenterLead Sponsor
Daniel H Chang, MDPrincipal InvestigatorEmpire Eye and Laser Center
~16 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top